Autonomic Nervous System, Adrenergic Antagonists Flashcards
What are adrenergic receptor antagonists?
drugs that inhibit the interactions of NE, EPI, and other sympathomimetics with α and β adrenergic receptors
How do α-antagonists receptor selectivity compare?
Prazosin, Terazosin, Doxasin - α1»»α2
Phenoxybenzamine - α1>α2
Phentolamine - α1=α2
Atipamezole, Yohimbine, Tolazoline - α2»α1
How does the mixed α- and β- antagonist receptor selectivity compare?
Carvedilol - β1=β2 >/= α1>α2
How do β-antagonists receptor selectivity compare?
Propranolol, Timolol - β1=β2
Metoprolol, Atenolol, Esmolol, Betaxolol - β1»>β2
What are the 3 categories of α-adrenoceptor antagonists? What kind of antagonists are they?
- β-haloethylamine alkylating agents: Phenoxybenzamine
- imidazoline analogs: Phentolamine, Tolazoline
- piperazinyl quinozolines: Prazosin
competitive antagonists
How are phenothiazine tranquilizers used? What selectivity do they demonstrate? What do they do?
potent α-adrenoceptor antagonist
substantial nonselective α-receptor clocking effects, leading to side effects
decrease peripheral vascular resistance secondary to antagonism of these receptors
What effect do α1-adrenergic receptor antagonists have on the cardiovascular system?
dilation of both arterial and venous vessels with an elimination of the increased peripheral vascular resistance to norepinephrine
What is the epinephrine reversal effect?
following pretreatment with an α1-adrenergic receptor agonist, administration of EPI may induce a reduction in peripheral vascular resistance and marked vasodilation mediated by the activation of β2-adrenergic receptors, resulting in a decrease in arterial blood pressure
What are some non-cardiovascular effects of α1, α2b, α2-adrenergic receptor antagonists?
α1 = decrease resistance to urine flow
α2b = antiaggregant in platelets,
α2 = stimulate insulin release from pancreatic islet cells, reverse sedation mediated by α2-adrenergic receptor agonists
How do α-adrenergic receptor antagonists affect the eye?
- protrusion of third eyelid
- miosis (constriction)
- nasal stuffiness
What is the main non-selective α1,α2 antagonist used in veterinary medicine? How does it bind to receptors? What does it do?
Phenoxybenzamine (α1>α2)
binds covalently to α-adrenergic receptors and produces and irreversible block
inhibits reuptake of NE at presynaptic nerve terminals
- can also antagonize at histamine, acetylcholine, and serotonin receptors
What is the predominant use of Phenoxybenzamine?
(non-selective α1>α2 antagonist)
manage the symptoms of catecholamine excess in the treatment of patients with a pheochromocytoma (tumor in adrenal medulla)
How do phenothiazine tranquilizers and the tetracyclic antidepressant trazodone work?
nonselective α1, α2 antagonists
What is Prazosin? What are 2 uses?
selective α1 antagonist
- treatment of hypertension - relaxes arterial and venous smooth muscle
- decrease resistance to urine flow in dogs with functional urethral obstructions, prostatic hyperplasia, and idiopathic vesicourethral reflext dyssynergia
What is thought to play a role in urethral obstruction recurrence? What is commonly used for postobstruction therapty?
urethral spasm
α1-receptor blockade (antagonists)
How does Prazosin compare to Phenoxybenzamine? What does administration to dogs result in?
higher α1-adrenergic receptor affinity
greater reduction of urethral pressure than phenoxybenzamine
- REMEMBER: α1 = sphincter contraction
Why is the efficacy of Prazosin in the treatment of urethral obstruction in cats debated?
antagonists usually acts on proximal urethra, and cats most commonly block at the distal portion
What is the most important limitation of α1-adrenergic receptor antagonists?
CARDIOVASCULAR EFFECTS:
- reduces vascular smooth muscle tone
- decreases systolic, diastolic, and mean arterial blood pressure
What is Tamsulosin? What receptor does it have the highest affinity for? Where are these receptors located?
second-generation α1-adrenergic receptor agonist
α1a (urethra/prostate in dogs) > α1b (vascular smooth muscle)
What is Silodosin?
third-generation α1-receptor antagonist